Suppr超能文献

MM-LDL诱导单核细胞与内皮细胞结合:脂氧合酶代谢产物的作用。

Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites.

作者信息

Honda H M, Leitinger N, Frankel M, Goldhaber J I, Natarajan R, Nadler J L, Weiss J N, Berliner J A

机构信息

Department of Medicine (Cardiology), Physiology, and Pathology and Laboratory Medicine, Cardiovascular Research Laboratory, University of California at Los Angeles, CA, USA.

出版信息

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):680-6. doi: 10.1161/01.atv.19.3.680.

Abstract

Treatment of human aortic endothelial cells (EC) with minimally oxidized LDL (or minimally modified LDL, MM-LDL) produces a specific pattern of endothelial cell activation distinct from that produced by LPS, tumor necrosis factor-alpha, and interleukin-1, but similar to other agents that elevate cAMP. The current studies focus on the signal transduction pathways by which MM-LDL activates EC to bind monocytes. We now demonstrate that, in addition to an elevation of cAMP, lipoxygenase products are necessary for the MM-LDL response. Treatment of EC with inhibitors of the lipoxygenase pathway, 5,8,11, 14-eicosatetraynoic acid (ETYA) or cinnamyl-3, 4-dihydroxy-alpha-cyanocinnamate (CDC), blocked monocyte binding in MM-LDL-treated EC (MM-LDL=118+/-13%; MM-LDL+ETYA=33+/-4%; MM-LDL+CDC=23+/-4% increase in monocyte binding) without reducing cAMP levels. To further investigate the role of the lipoxygenase pathway, cellular phospholipids were labeled with arachidonic acid. Treatment of cells for 4 hours with 50 to 100 microg/mL MM-LDL, but not native LDL, caused a 60% increase in arachidonate release into the medium and increased the intracellular formation of 12(S)-HETE (approximately 100% increase). There was little 15(S)-HETE present, and no increase in its levels was observed. We demonstrated that 12(S)-HETE reversed the inhibitory effect of CDC. We also observed a 70% increase in the formation of 11,12-epoxyeicosatrienoic acid (11, 12-EET) in cells treated with MM-LDL. To determine the mechanism of arachidonate release induced by MM-LDL, we examined the effects of MM-LDL on intracellular calcium levels. Treatment of EC with both native LDL and MM-LDL caused a rapid release of intracellular calcium from internal stores. However, several pieces of evidence suggest that calcium release alone does not explain the increased arachidonate release in MM-LDL-treated cells. The present studies suggest that products of 12-lipoxygenase play an important role in MM-LDL action on the induction of monocyte binding to EC.

摘要

用轻度氧化的低密度脂蛋白(或轻度修饰的低密度脂蛋白,MM-LDL)处理人主动脉内皮细胞(EC)会产生一种特定模式的内皮细胞激活,这种激活模式不同于脂多糖、肿瘤坏死因子-α和白细胞介素-1所产生的激活模式,但类似于其他能提高环磷酸腺苷(cAMP)的物质所产生的激活模式。目前的研究聚焦于MM-LDL激活内皮细胞以结合单核细胞的信号转导途径。我们现在证明,除了cAMP升高外,脂氧合酶产物对于MM-LDL反应也是必需的。用脂氧合酶途径抑制剂5,8,11,14-二十碳四烯酸(ETYA)或肉桂酰-3,4-二羟基-α-氰基肉桂酸(CDC)处理内皮细胞,可阻断MM-LDL处理的内皮细胞中的单核细胞结合(MM-LDL处理组单核细胞结合增加118±13%;MM-LDL+ETYA组为33±4%;MM-LDL+CDC组为23±4%),且不会降低cAMP水平。为了进一步研究脂氧合酶途径的作用,用花生四烯酸标记细胞磷脂。用50至100μg/mL的MM-LDL处理细胞4小时,而非天然低密度脂蛋白,会使花生四烯酸释放到培养基中的量增加60%,并使细胞内1,2(S)-羟基二十碳四烯酸(12(S)-HETE)的生成增加(约100%)。几乎没有检测到15(S)-HETE,且其水平没有增加。我们证明12(S)-HETE可逆转CDC的抑制作用。我们还观察到,用MM-LDL处理的细胞中11,12-环氧二十碳三烯酸(11,12-EET)的生成增加了70%。为了确定MM-LDL诱导花生四烯酸释放的机制,我们研究了MM-LDL对细胞内钙水平的影响。用天然低密度脂蛋白和MM-LDL处理内皮细胞均会导致细胞内钙从内部储存库快速释放。然而,多项证据表明,仅钙释放并不能解释MM-LDL处理的细胞中花生四烯酸释放增加的现象。目前的研究表明,12-脂氧合酶产物在MM-LDL诱导单核细胞与内皮细胞结合的作用中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验